Æ÷µµ¸·¿° Ä¡·áÁ¦ ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - Ä¡·á À¯Çüº°, Áúȯ À¯Çüº°, ¿øÀκ°, À¯Åë ä³Îº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Uveitis Drugs Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type, By Disease Type, by Cause, By Distribution Channel, By Region & Competition, 2020-2030F
»óǰÄÚµå : 1728091
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 180 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,197,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,574,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,017,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è Æ÷µµ¸·¿° Ä¡·áÁ¦ ½ÃÀåÀº 2024³â 7¾ï 530¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2030³â±îÁö CAGRÀº 7.20%·Î ¿¹Ãø ±â°£ µ¿¾È °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Æ÷µµ¸·¿°Àº ȫä, ¸ð¾çü, ¸Æ¶ô¸·À» Æ÷ÇÔÇÑ ¾È±¸ÀÇ Áß°£ÃþÀÎ Æ÷µµ¸·¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿°Áõ¼º ¾ÈÁúȯ±ºÀ» ¸»ÇÕ´Ï´Ù. Æ÷µµ¸·¿°À» ¹æÄ¡ÇÏ¸é ½É°¢ÇÑ ½Ã·ÂÀå¾Ö³ª ½Ç¸í¿¡ À̸¦ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ÁúȯÀº °¨¿°, ÀÚ°¡¸é¿ªÁúȯ, ¿Ü»ó¿¡ ÀÇÇØ À¯¹ßµÇ´Â °æ¿ì¿Í Ư¹ß¼ºÀÏ ¼ö ÀÖ½À´Ï´Ù. ÁÖ¿ä Áõ»óÀ¸·Î´Â ´«ÀÇ ÅëÁõ, ÃæÇ÷, ´«ºÎ½É, ´«ºÎ½É, ºû °ú¹ÎÁõ, ºÎÀ¯°¨ µîÀÌ ÀÖ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î °í·ÉÈ­ »çȸ°¡ ÁøÇàµÇ¸é¼­ ³ëÈ­¿¡ µû¸¥ ¾ÈÁúȯÀÌ ¸¸¿¬ÇÔ¿¡ µû¶ó È¿°úÀûÀÎ Æ÷µµ¸·¿° Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Ä¡·áÁ¦ÀÇ ¹ßÀüÀº ÀνÄÀÇ Áõ°¡¿Í Áø´Ü ´É·ÂÀÇ Çâ»ó°ú ÇÔ²² ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é, 60¼¼ ÀÌ»ó Àα¸´Â 2015³â 9¾ï ¸í¿¡¼­ 2050³â±îÁö 20¾ï ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ·Î ÀÎÇØ Æ÷µµ¸·¿°°ú °°Àº ¾ÈÁúȯÀÇ ºÎ´ãÀÌ Áõ°¡ÇÏ¿© È¿°úÀûÀÎ ¾à¹° Ä¡·áÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 7¾ï 530¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 10¾ï 6,182¸¸ ´Þ·¯
CAGR : 2025-2030³â 7.20%
±Þ¼ºÀå ºÎ¹® ¿Â¶óÀÎ ¾à±¹
ÃÖ´ë ½ÃÀå ºÏ¹Ì

ÁÖ¿ä ½ÃÀå ÃËÁø¿äÀÎ

Ä¡·á ¿É¼ÇÀÇ ¹ßÀü

ÁÖ¿ä ½ÃÀå °úÁ¦

Ä¡·áºñ Æøµî

ÁÖ¿ä ½ÃÀå µ¿Çâ

ȯÀÚ Áß½ÉÀû Á¢±Ù

¸ñÂ÷

Á¦1Àå Á¦Ç° °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¼Ò¸®

Á¦5Àå ¼¼°èÀÇ Æ÷µµ¸·¿° Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦6Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Æ÷µµ¸·¿° Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ Æ÷µµ¸·¿° Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦8Àå ºÏ¹ÌÀÇ Æ÷µµ¸·¿° Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦9Àå ³²¹ÌÀÇ Æ÷µµ¸·¿° Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Æ÷µµ¸·¿° Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦11Àå ½ÃÀå ¿ªÇÐ

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦13Àå ¼¼°èÀÇ Æ÷µµ¸·¿° Ä¡·áÁ¦ ½ÃÀå : SWOT ºÐ¼®

Á¦14Àå Porter's Five Forces ºÐ¼®

Á¦15Àå PESTEL ºÐ¼®

Á¦16Àå °æÀï ±¸µµ

Á¦17Àå Àü·«Àû Á¦¾È

Á¦18Àå Á¶»ç ȸ»ç ¼Ò°³ ¹× ¸éÃ¥»çÇ×

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Uveitis Drugs Market was valued at USD 705.30 million in 2024 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 7.20% through 2030F. Uveitis refers to a group of inflammatory eye conditions affecting the uvea, the eye's middle layer, which includes the iris, ciliary body, and choroid. If left untreated, uveitis can lead to serious vision impairment or even blindness. The condition may be caused by infections, autoimmune disorders, trauma, or may be idiopathic. Key symptoms include eye pain, redness, blurred vision, light sensitivity, and floaters. With the global aging population on the rise and age-related eye disorders becoming more prevalent, demand for effective uveitis treatments is increasing. Advances in therapeutic formulations, coupled with heightened awareness and improved diagnostic capabilities, are further supporting market expansion. According to the World Health Organization, the population aged 60 and over is expected to grow from 900 million in 2015 to 2 billion by 2050, increasing the burden of ocular diseases such as uveitis and driving the need for effective drug therapies.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 705.30 Million
Market Size 2030USD 1061.82 Million
CAGR 2025-20307.20%
Fastest Growing SegmentOnline Pharmacies
Largest MarketNorth America

Key Market Drivers

Advancements in Treatment Options

Innovative treatment modalities have significantly enhanced uveitis management in recent years. Biologics, such as adalimumab and infliximab, offer targeted therapy by modulating the immune response responsible for inflammation. Sustained-release corticosteroid implants, including dexamethasone-based options, have improved patient compliance by reducing the frequency of administration. Intravitreal injections and advanced topical formulations have gained popularity for delivering drugs directly to the affected area while minimizing systemic side effects. In March 2025, ANI Pharmaceuticals received FDA approval for an expanded indication of ILUVIEN (fluocinolone acetonide intravitreal implant) for treating chronic non-infectious uveitis of the posterior segment (NIU-PS). This move reinforces the shift toward longer-lasting, targeted therapies in uveitis treatment. These developments underscore the growing availability of effective, patient-friendly options that are helping reshape the treatment landscape for this potentially sight-threatening condition.

Key Market Challenges

High Cost of Treatment

The cost burden associated with uveitis treatment continues to be a key constraint, especially in resource-limited settings. Advanced drugs such as biologics and intravitreal implants can be expensive, often exceeding affordability thresholds for uninsured or underinsured patients. Chronic disease management requires continuous medication, regular monitoring, and specialist consultations, all of which drive long-term healthcare expenditures. In many cases, limited access to eye care professionals and diagnostic facilities compounds these challenges, particularly in rural or underserved regions. High treatment costs may result in poor adherence or delayed treatment, thereby increasing the risk of complications and irreversible vision loss. Healthcare systems also face economic strain, with the rising prevalence of uveitis increasing demand for cost-intensive care. These barriers emphasize the urgent need for affordable treatment options, including the introduction of generics and biosimilars, to improve accessibility and reduce the financial burden on patients and providers alike.

Key Market Trends

Patient-Centric Approaches

A notable trend in the uveitis drugs market is the shift toward personalized, patient-centered care. Healthcare providers are tailoring treatment strategies based on disease subtype, severity, patient health status, and individual preferences. Shared decision-making between clinicians and patients fosters better adherence and outcomes. Enhanced patient education initiatives focus on raising awareness about uveitis symptoms, treatment importance, and disease monitoring. This approach is supported by the implementation of simplified treatment regimens and reminder systems to boost adherence. Emphasis is also placed on improving quality of life through comprehensive management plans that address the physical, psychological, and social effects of the disease. Access to educational resources and patient advocacy networks is helping individuals navigate the complexities of long-term disease management, creating a more engaged and informed patient base. These strategies reflect a broader healthcare trend focused on empowering patients and optimizing long-term outcomes.

Key Market Players

Report Scope:

In this report, the Global Uveitis Drugs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Uveitis Drugs Market, By Treatment Type:

Uveitis Drugs Market, By Disease Type:

Uveitis Drugs Market, By Cause:

Uveitis Drugs Market, By Distribution Channel:

Uveitis Drugs Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Uveitis Drugs Market.

Available Customizations:

Global Uveitis Drugs Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Uveitis Drugs Market Outlook

6. Asia Pacific Uveitis Drugs Market Outlook

7. Europe Uveitis Drugs Market Outlook

8. North America Uveitis Drugs Market Outlook

9. South America Uveitis Drugs Market Outlook

10. Middle East and Africa Uveitis Drugs Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Global Uveitis Drugs Market: SWOT Analysis

14. Porter's Five Forces Analysis

15. PESTLE Analysis

16. Competitive Landscape

17. Strategic Recommendations

18. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â